Loading clinical trials...
Loading clinical trials...
To assess the efficacy of oral aliskiren as a therapy for diabetic macular edema
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis Pharmaceuticals
NCT07425522 · Diabetic Macular Edema
NCT07308639 · Neovascular Age-related Macular Degeneration (nAMD); Diabetic Macular Edema (DME); Retinal Vein Occlusion (RVO)
NCT07520045 · Diabetic Retinopathy (DR), Diabetic Macular Edema (DME)
NCT07449936 · Diabetic Macular Edema, DME, and more
NCT07362927 · Diabetic Macular Edema (DME)
Retinal Consultants of Arizona
Phoenix, Arizona
Retina-Vitreous Associates
Los Angeles, California
National Ophthalmic Research Institute
Fort Myers, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions